Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:November 9, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Hepatocellular CarcinomaLast Updated:November 9, 2010Completed
Condition(s):Breast Cancer; Breast Disease; Neoplasms; Neoplasms by SiteLast Updated:May 9, 2017Completed
Condition(s):Urothelial CarcinomaLast Updated:March 15, 2018Terminated
Condition(s):Metastatic OsteosarcomaLast Updated:February 4, 2013Completed
Condition(s):Breast CancerLast Updated:December 19, 2023Completed
Condition(s):Triple Negative Breast CancerLast Updated:March 4, 2024Recruiting
Condition(s):Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Untreated Childhood Acute Lymphoblastic LeukemiaLast Updated:September 19, 2014Completed
Condition(s):RhabdomyosarcomaLast Updated:May 10, 2023Recruiting
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:April 25, 2013Completed
Condition(s):Ataxia-TelangiectasiaLast Updated:August 27, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.